Medical Research and Clinical Trials

Novo Nordisk Halts Two Key Heart Failure Trials for Ziltivekimab Amidst Setbacks, Shifts Focus to Acute Treatment

• Medical Research and Clinical Trials

Novo Nordisk Halts Two Key Heart Failure Trials for Ziltivekimab Amidst Setbacks, Shifts Focus to Acute Treatment

Nana Muazin September 7, 2026

Copenhagen, Denmark – September 15, 2023 – In a significant pivot for its cardiovascular pipeline, global pharmaceutical...

Read More Read more about Novo Nordisk Halts Two Key Heart Failure Trials for Ziltivekimab Amidst Setbacks, Shifts Focus to Acute Treatment

Unlocking New Hope: USC Researchers Discover Potent Combination Therapy Extending Glioblastoma Survival

• Medical Research and Clinical Trials

Unlocking New Hope: USC Researchers Discover Potent Combination Therapy Extending Glioblastoma Survival

Nana September 7, 2026

LOS ANGELES, CA – [Current Date] – In a significant breakthrough offering a beacon of hope for...

Read More Read more about Unlocking New Hope: USC Researchers Discover Potent Combination Therapy Extending Glioblastoma Survival

Breakthrough in Breast Cancer Care: Penn Medicine Unlocks Key to Preventing Recurrence by Targeting Dormant Cells

• Medical Research and Clinical Trials

Breakthrough in Breast Cancer Care: Penn Medicine Unlocks Key to Preventing Recurrence by Targeting Dormant Cells

Lina Hope September 7, 2026

PHILADELPHIA, PA – A groundbreaking, federally funded clinical trial has unveiled a revolutionary approach to breast cancer...

Read More Read more about Breakthrough in Breast Cancer Care: Penn Medicine Unlocks Key to Preventing Recurrence by Targeting Dormant Cells

Revolutionary IgE Antibody Awakens Immune System to Combat Ovarian Cancer

• Medical Research and Clinical Trials

Revolutionary IgE Antibody Awakens Immune System to Combat Ovarian Cancer

Ali Ikhwan September 6, 2026

London, UK – In a landmark development that could redefine the landscape of cancer immunotherapy, researchers at...

Read More Read more about Revolutionary IgE Antibody Awakens Immune System to Combat Ovarian Cancer

Navigating Menopause: New Research Sheds Light on Hormone Therapy’s Long-Term Cardiovascular Impact

• Medical Research and Clinical Trials

Navigating Menopause: New Research Sheds Light on Hormone Therapy’s Long-Term Cardiovascular Impact

Iffa Jayyana September 6, 2026

PHILADELPHIA, PA – The journey through menopause, a pivotal life phase marking the cessation of a woman’s...

Read More Read more about Navigating Menopause: New Research Sheds Light on Hormone Therapy’s Long-Term Cardiovascular Impact

Breakthrough in Glioblastoma Research: Rogue DNA Rings Identified as Key Drivers, Opening New Avenues for Early Detection and Treatment

• Medical Research and Clinical Trials

Breakthrough in Glioblastoma Research: Rogue DNA Rings Identified as Key Drivers, Opening New Avenues for Early Detection and Treatment

Jia Lissa September 6, 2026

London, UK & Stanford, USA – September 8, 2023 – In a landmark scientific discovery offering a...

Read More Read more about Breakthrough in Glioblastoma Research: Rogue DNA Rings Identified as Key Drivers, Opening New Avenues for Early Detection and Treatment

Treeline Biosciences Partners with Roche for Groundbreaking B-Cell Lymphoma Trial

• Medical Research and Clinical Trials

Treeline Biosciences Partners with Roche for Groundbreaking B-Cell Lymphoma Trial

Rifan Muazin September 6, 2026

San Francisco, CA – [Insert Date] – In a significant development for the treatment of B-cell lymphomas...

Read More Read more about Treeline Biosciences Partners with Roche for Groundbreaking B-Cell Lymphoma Trial

AbbVie’s Etentamig Shows Promise in Phase III Trial, Poised to Disrupt Competitive Multiple Myeloma Market

• Medical Research and Clinical Trials

AbbVie’s Etentamig Shows Promise in Phase III Trial, Poised to Disrupt Competitive Multiple Myeloma Market

Dwi Wanna September 5, 2026

CHICAGO, IL – AbbVie’s novel bispecific T-cell engager (BiTE) therapy, etentamig, has demonstrated significant positive impact on...

Read More Read more about AbbVie’s Etentamig Shows Promise in Phase III Trial, Poised to Disrupt Competitive Multiple Myeloma Market

Breakthrough Combination Therapy Offers New Hope for Men with Advanced Prostate Cancer

• Medical Research and Clinical Trials

Breakthrough Combination Therapy Offers New Hope for Men with Advanced Prostate Cancer

Reynand Wu September 5, 2026

London, UK – A landmark international study, spearheaded by researchers at University College London (UCL), has unveiled...

Read More Read more about Breakthrough Combination Therapy Offers New Hope for Men with Advanced Prostate Cancer

Ivonescimab Achieves Significant Overall Survival Milestone in First-Line Lung Cancer, Bolstering Global Regulatory Push

• Medical Research and Clinical Trials

Ivonescimab Achieves Significant Overall Survival Milestone in First-Line Lung Cancer, Bolstering Global Regulatory Push

Lina Hope September 5, 2026

Akeso and Summit Therapeutics’ novel bispecific antibody, ivonescimab, has demonstrated a significant improvement in overall survival (OS)...

Read More Read more about Ivonescimab Achieves Significant Overall Survival Milestone in First-Line Lung Cancer, Bolstering Global Regulatory Push